Press Release Sep 30 2021

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 30, 2021, titled "Glenmark receives marketing approval for Ryaltris��, an innovative combination nasalspray, in 13 countries across the EU and UK".

View Attachment